Retatrutide Smart Pen An investigational triple receptor agonist (GLP-1, GIP, glucagon)
April 28, 2025
It plays a crucial role in slowing gastric emptying, stimulating insulin production, and reducing food cravings and intake ( Building on these findings, the investigation was quickly extended to drug-related rewards, and a growing body of preclinical studies across a range of substances suggests that GLP-1 receptor agonists can reduce behavioral patterns associated with addiction
In a 2014 randomised trial of ipamorelin for postoperative ileus, treatment-emergent adverse events occurred in 87.5% of the ipamorelin group versus 94.8% of the placebo group over up to seven days of intravenous dosing
Effects of physical activity on cell-to-cell communication during type 2 diabetes: A focus on miRNA signaling
Companies such as Novo Nordisk and Eli Lilly have sent cease-and-desist letters to parties involved in the manufacture, sale, and distribution of unauthorized GLP-1 products